Healthcare -
Biotechnology - NASDAQ - US
$ 5.435
-1.54 %
$ 372 M
Market Cap
-0.95
P/E
PHAT - INTEREST INCOME & EXPENSE
Interest Income & Expense PHAT - Phathom Pharmaceuticals, Inc.
42 M
LAST VALUE
148.65%
2 YEAR CAGR
403.26%
5 YEAR CAGR
0.00%
10 YEAR CAGR